Bernard Bochner joins Ashish Kamat in this discussion discussing the advancements throughout 2020 in muscle-invasive non-metastatic bladder cancer. It would be impossible to discuss the year without mentioning the impact of COVID-19. There are some diseases that can withstand treatment delay, but muscle-invasive bladder cancer is not one of those tumors. These challenges pushed the bladder…
Prostate cancer, stereotactic body radiotherapy (SBRT), Urethra-Sparing Stereotactic Body Radiotherapy, Urethra-Sparing Stereotactic Body Radiotherapy for Prostate Cancer, magnetic resonance guided radiotherapy (MRgRT).
Ruchika Talwar interviews Daniel Joyce about his journey into cost-effectiveness studies, particularly in testicular cancer. Initially skeptical, Dr. Joyce now sees these studies as crucial…
Rashid Sayyid and Zach Klaassen delve into the significance of racial disparities in prostate cancer treatment through a subgroup analysis of the ARASENS trial, which…
Program: State-of-the-Art Interdisciplinary Management of Prostate Cancer This series is part of an Independent Medical Education Initiative Supported by BAYER U.S. LLC PHARMACEUTICALS Biographies: Zachary…
Zach Klaassen engages in a discussion with Vahan Kassabian about the evolving landscape of nonmetastatic castration-resistant prostate cancer (nmCRPC) management. They delve into how novel…
Ashish Kamat and Mark Tyson discuss the currently enrolling PIVOT-006 study. Dr. Tyson discusses cretostimogene grenadenorepvec, a conditionally replicating oncolytic adenovirus designed for cancer cell…
metastatic castration-sensitive prostate cancer (mCSPC), apalutamide treatment effect in TITAN patients with mCSPC, phase III randomised TITAN study, robust benefit with apalutamide plus ADT.
Ruchika Talwar speaks with Chana Weinstock about the recent chemotherapy shortage affecting genitourinary cancers, notably muscle-invasive bladder cancer. Dr. Weinstock explains the complexity behind drug…
Robot-Assisted PSMA-Radioguided Surgery, Prostate Cancer, radical prostatectomy, Confocal microscopy, PSMA PET/CT, 68Ga-PSMA-11, robot-assisted radical prostatectomy (RARP), pelvic lymph node dissection (PLND), AURA 10 specimen PET/CT…
Alicia Morgans and Cheryl Lee discuss the need for equitable representation in clinical trials. Dr. Lee emphasizes the underrepresentation of minorities, low-income individuals, and those…
